The news comes as Johnson & Johnson (J&J) said it's seeking up to a $42.95 billion valuation for Kenvue in its initial public offering. Earlier this month, J&J agreed to pay $8.9 billion to settle tens of thousands of lawsuits alleging that talc in its iconic Baby Powder and other products caused cancer, dwarfing the company's original offer of $2 billion. J&J has claimed that its talc products are safe and do not cause cancer. One of the new cases naming Kenvue was filed in Middlesex county, New Jersey, on behalf of a husband and wife who live in Louisiana, FT said. Their lawsuit claims Justin Bergeron contracted mesothelioma as a result of using J&J talc containing asbestos, FT reported. Lawyers working for talc claimants said it could be the first of many claims filed against Kenvue and other J&J divisions not previously named in lawsuits, the paper added. J&J did not immediately respond to a Reuters request for comment on the lawsuits.
(Reporting by Jyoti Narayan in Bengaluru; Editing by Rashmi Aich)